WWMSC
TCRR

Wagner Wealth Management (South Carolina)’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-275
Closed – – 733
2022
Q3 		$0 Hold
275
– – ﹤0.01% 792
2022
Q2 		$1K Buy
+275
New +$678 ﹤0.01% 688
2022
Q1 		– Sell
-366
Closed -$2K – 694
2021
Q4 		$2K Hold
366
– – ﹤0.01% 647
2021
Q3 		$2K Hold
366
– – ﹤0.01% 615
2021
Q2 		$6K Hold
366
– – ﹤0.01% 559
2021
Q1 		$8K Buy
+366
New +$9.98K 0.01% 494

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s TCRR Position: Q4 2022 in Review

Wagner Wealth Management (South Carolina) sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2022, closing a stake of 275 shares.

Wagner Wealth Management (South Carolina) first reported a position in TCRR in Q1 2021 and held it in 6 quarters. The position peaked at $8K in Q1 2021. 63 funds tracked by Wall St. Rank hold TCRR as of Q4 2022.

  • Wagner Wealth Management (South Carolina) reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 275 TCR2 Therapeutics Inc. Common Stock shares in Q4 2022.
  • Wagner Wealth Management (South Carolina) first reported a position in TCR2 Therapeutics Inc. Common Stock in Q1 2021 and held it in 6 quarters.
  • Wagner Wealth Management (South Carolina)'s TCR2 Therapeutics Inc. Common Stock position peaked at $8K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2022.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q4 2022, filed 14 Feb 2023.